CEFAZOLIN AND DEXTROSE Drug Patent Profile
✉ Email this page to a colleague
When do Cefazolin And Dextrose patents expire, and what generic alternatives are available?
Cefazolin And Dextrose is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in CEFAZOLIN AND DEXTROSE is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefazolin And Dextrose
A generic version of CEFAZOLIN AND DEXTROSE was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
Summary for CEFAZOLIN AND DEXTROSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| Clinical Trials: | 157 |
| Patent Applications: | 3,003 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CEFAZOLIN AND DEXTROSE at DailyMed |
Recent Clinical Trials for CEFAZOLIN AND DEXTROSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Abdul El-Rabbany | Phase 4 |
| Assistance Publique Hopitaux De Marseille | Phase 4 |
| Leiden University Medical Center | Phase 4 |
Pharmacology for CEFAZOLIN AND DEXTROSE
| Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFAZOLIN AND DEXTROSE
US Patents and Regulatory Information for CEFAZOLIN AND DEXTROSE
CEFAZOLIN AND DEXTROSE is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting CEFAZOLIN AND DEXTROSE
NEW PATIENT POPULATION
Exclusivity Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-002 | Jul 27, 2000 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-003 | Jan 13, 2012 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-001 | Jul 27, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
